Search results:
Found 2
Listing 1 - 2 of 2 |
Sort by
|
Choose an application
The impact of fat intake on hypercholesterolemia and related atherosclerotic cardiovascular diseases has been studied for decades. However, the current evidence base suggests that fatty acids also influences cardiometabolic diseases through other mechanisms including effects on glucose metabolism, body fat distribution, blood pressure, inflammation, and heart rate. Furthermore, studies evaluating single fatty acids have challenged the simplistic view of shared health effects within fatty acid groups categorized by degree of saturation. In addition, investigations of endogenous fatty acid metabolism, including genetic studies of fatty acid metabolizing enzymes, and the identification of novel metabolically derived fatty acids have further increased the complexity of fatty acids’ health impacts. This Special Issue aims to include original research and up-to-date reviews on genetic and dietary modulation of fatty acids, and the role and function of dietary and metabolically derived fatty acids in cardiometabolic health.
omega-3 --- cardiovascular disease --- statins --- type 2 diabetes mellitus --- medium-chain triglyceride --- long-chain triglyceride --- lipid metabolism --- klotho --- CKD --- fish oil --- fibrosis --- inflammation --- cardiometabolic disease --- unsaturated fat --- Mediterranean diet --- low-fat diet --- alternatively activated macrophages --- perivascular adipose tissue --- type 2 cytokines --- erucic acid --- fish --- seafood --- furan fatty acids --- docosapentaenoic acid --- conjugated fatty acids --- cardiovascular disease --- metabolic disease --- blood lipids --- inflammation --- antioxidant --- CYP450 eicosanoids --- omega-3 PUFA --- omega-6 PUFA --- blood pressure --- hemodynamics --- children --- EETs --- EEQs --- fatty acid --- diet --- genotype --- human --- FADS --- fatty acid --- desaturase --- Genome-wide association study (GWAS) --- Insulin sensitivity --- adipose tissue --- cholesterol ester --- omega 3 --- PUFA --- n-3 PUFA --- COPD --- inflammation --- coronary artery disease --- ischemic heart disease --- CAD --- CHD --- fat --- obesity --- body weight --- cohort study --- substitution models --- epidemiology --- prospective cohort study --- n-6 fatty acids --- n-3 fatty acids --- linoleic acid --- arachidonic acid
Choose an application
The natriuretic peptides (NPs) family includes a class of hormones and their receptors needed for the physiological control of cardiovascular functions. The discovery of NPs provided a fundamental contribution into our understanding of the physiological regulation of blood pressure, and of heart and kidney functions. NPs have also been implicated in the pathogenesis of several cardiovascular diseases (CVDs), including hypertension, atherosclerosis, heart failure, and stroke. A fine comprehension of the molecular mechanisms dependent from NPs and underlying the promotion of cardiovascular damage has contributed to improve our understanding of the molecular basis of all major CVDs. Finally, the opportunity to target NPs in order to develop new therapeutic tools for a better treatment of CVDs has been developed over the years. The current Special Issue of the Journal covers all major aspects of the molecular implications of NPs in physiology and pathology of the cardiovascular system, including NP-based therapeutic approaches.
PCSK9 --- natriuretic peptides --- adipose tissue --- lipid metabolism --- LDL receptor --- insulin --- natriuretic peptides --- hypertension --- stroke --- cardiac hypertrophy --- linkage analysis --- genetic variants --- animal models --- BNP --- NT-proBNP --- heart failure --- cardiac dysfunction --- forensic medicine --- postmortem biochemistry --- angiotensin receptor–neprilysin inhibitor --- natriuretic peptides --- renin–angiotensin system --- heart failure --- arterial hypertension --- natriuretic peptide --- vascular --- endothelial cell --- cardiomyocyte --- fibroblast --- inflammation --- heart failure --- hypertension --- angiogenesis --- heart failure --- natriuretic peptides --- preserved ejection fraction --- natriuretic peptides --- heart failure --- atrial fibrillation --- remodeling --- Idiopathic Pulmonary Arterial Hypertension (IPAH) --- Natriuretic Peptide Clearance Receptor (NPR-C) signaling --- atrial natriuretic peptide --- hypertension --- heart failure --- cardiometabolic disease --- obesity --- metabolic syndrome --- cGMP --- guanylyl cyclase receptor A --- natriuretic peptides --- natriuretic peptide --- cardiorenal syndrome --- vasopressor --- vasodilator --- kidney --- medulla --- renin-angiotensin-aldosterone system --- Atrial Natriuretic peptide --- natriuretic peptides --- cardiac remodelling --- cardiac hypertrophy --- vascular homeostasis --- atrial natriuretic peptide --- guanylyl cyclase/natriuretic peptide receptor-A --- gene-knockout --- gene-duplication --- hypertension --- congestive heart failure --- natriuretic peptides --- arterial hypertension --- pulmonary arterial hypertension --- heart failure --- stroke --- atrial fibrillation --- ARNi --- MANP
Listing 1 - 2 of 2 |
Sort by
|
2019 (2)